The Technical Analyst
Select Language :
InMed Pharmaceuticals [INM]

Exchange: NASDAQ Sector: Healthcare Industry: Biotechnology

InMed Pharmaceuticals Price, Forecast, Insider, Ratings, Fundamentals & Signals

InMed Pharmaceuticals is listed at the  Exchange

9.64% $0.364

America/New_York / 28 mar 2024 @ 16:00


InMed Pharmaceuticals: Main Fundamentals PE comparison

FUNDAMENTALS
MarketCap: 2.20 mill
EPS: -0.420
P/E: -0.870
Earnings Date: May 12, 2024
SharesOutstanding: 6.06 mill
Avg Daily Volume: 0.168 mill
RATING 2024-03-28
B
Neutral
RATINGS
Rating CashFlow: Neutral
Return On Equity: Sell
Return On Asset: Neutral
DE: Neutral
P/E: Sell
Price To Book: Neutral
QUARTER GROWTHS
3/224/221/232/233/234/23
Revenue
Gr.Profit
Ebit
Asset
Debt
PE RATIO: COMPANY / SECTOR
0.00x
Company: PE -0.870 | sector: PE -3.05
PE RATIO: COMPANY / INDUSTRY
-0.15x
Company: PE -0.870 | industry: PE 5.88
DISCOUNTED CASH FLOW VALUE
N/A
N/A
Expected Trading Range (DAY)

$ 0.317 - 0.411

( +/- 12.91%)
ATR Model: 14 days

Insider Trading

Date Person Action Amount type
2024-01-14 Hull Andrew Sell 42 Employee Stock Option (Expiration)
2024-03-04 Hsu Eric C Sell 309 Employee Stock Option (Expiration)
2024-01-21 Mancini Alexandra Diane Janet Sell 121 Employee Stock Option (Expiration)
2024-02-20 Jagpal Netta Sell 50 000 Employee Stock Option (Right to Buy)
2024-02-21 Hull Andrew Buy 37 500 Common Stock
INSIDER POWER
73.91
Last 93 transactions
Buy: 1 291 573 | Sell: 391 310

Live Trading Signals (every 1 min)

Forecast 1: 16:00 - $0.364
Forecast 2: 16:00 - $0.364
Forecast 3: 16:00 - $0.364
SCORE
10.00
Buy
Score Algorithm Version: 1.2C
Last version updated: Fri April 15th, 2022
Indicator Signals
RSI 21
SMA
Trend
Trend 2
Trend 3
MACD
Volume Signals
Price $0.364 (9.64% )
Volume 0.0598 mill
Avg. Vol. 0.168 mill
% of Avg. Vol 35.55 %
Signal 1:
Signal 2:

Today

Intraday chart data with high, low, open and close for InMed Pharmaceuticals Inc.

Last 12 Months

Last 12 months chart data with high, low, open and close for InMed Pharmaceuticals Inc.

RSI

Last 10 Buy & Sell Signals For INM

0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%

Avg return buy: 0.00 % | Avg return sell: 0.00 %

$1 invested is now $1.00 or 0.00% since Coming Soon

Date Signal @ Closed %
Profile picture for
            InMed Pharmaceuticals Inc.

INM

InMed Pharmaceuticals Inc., a clinical stage pharmaceutical company, researches and develops cannabinoid-based therapies. The company's lead product is INM-755, a cannabinol topical cream, which is in a second Phase I clinical trials for the treatment of epidermolysis bullosa. The company is also involved in developing INM-088, which is in preclinical studies for the treatment of glaucoma; and INM-405 for the treatment of pain. In addition, it engages in the development of cannabinoid-based treatments for various diseases, including dermatology and ocular diseases. Further, the company works on IND-enabling pharmacology and preclinical toxicology studies; and IntegraSyn, an integrated biosynthesis-based manufacturing approach, for synthesizing pharmaceutical-grade cannabinoids. It has a research collaboration agreement with BayMedica Inc. for the manufacturing and testing of novel cannabinoid therapeutics. The company was formerly known as Cannabis Technologies Inc. and changed its name to InMed Pharmaceuticals Inc. in October 2014. InMed Pharmaceuticals Inc. was incorporated in 1981 and is headquartered in Vancouver, Canada.

Last 10 Buy Signals

Date Signal @
RARIUSDMar 29 - 11:533.45
TBTCUSDMar 29 - 11:4769 358
ETHWUSDMar 29 - 11:465.02
VRXUSDMar 29 - 11:4670.54
WMNTUSDMar 29 - 11:431.160
STSOLUSDMar 29 - 11:44218.73
RAYUSDMar 29 - 11:44$1.922
ORCAUSDMar 29 - 11:433.89
GALXUSDMar 29 - 11:434.95
HAPIUSDMar 29 - 11:4422.87

Latest Press Releases

Latest News

Disclaimer:

"JimStromberg.com" is a research service that provides financial data and technical analysis of publicly traded stocks. All users should speak with their financial advisor before buying or selling any securities. Users should not base their investment decision upon "JimStromberg.com". By using the site you agree and are held liable for your own investment decisions and agree to Terms of Use and Privacy Policy. Please read the full disclaimer here.